Xiaoqing He

Viral Kinetics and Antibody Responses in Patients with COVID-19

Wenting Tan, Yanqiu Lu, Juan Zhang et al. · medRxiv · 2020 · 343 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol

Yanming Zeng, Xiao-Lei Xu, Xiaoqing He et al. · Chinese Medical Journal · 2020 · 64 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +13

No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study

Yin-Qiu Huang, Shengquan Tang, Xiao-Lei Xu et al. · Frontiers in Pharmacology · 2020 · 55 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Hepatoprotection by Ginsenoside Rg1 in alcoholic liver disease

Cheng Yang, Xiaoqing He, Jinqiu Zhao et al. · International Immunopharmacology · 2021 · 44 citations

Medicine, Internal Medicine, Apoptosis +12

Preference for daily versus on‐demand pre‐exposure prophylaxis for HIV and correlates among men who have sex with men: the China Real‐world Oral PrEP Demonstration study

Jing Zhang, Junjie Xu, Hongyi Wang et al. · Journal of the International AIDS Society · 2021 · 44 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +17